MH

Mahendrasingh Hanumansingh Chauhan

Active Director Designated Partner DIN 11736397
DIN 11736397 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahendrasingh Hanumansingh Chauhan

Data last updated:

Mahendrasingh Hanumansingh Chauhan is a Designated Partner at Ai Prime Pathology And Diagnostics Llp (since 2026).

DIN 11736397
Primary Designation Designated Partner
First Appointment 22 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 May 20262026Active

Board colleagues of Mahendrasingh Hanumansingh Chauhan

Directorship timeline

Open interactive timeline →
Ai Prime Pathology And Diagnostics Llp
Premium access

Shareholding and investment profile for Mahendrasingh Hanumansingh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendrasingh Hanumansingh Chauhan

Mahendrasingh Hanumansingh Chauhan currently holds 1 directorship: Ai Prime Pathology And Diagnostics Llp (Designated Partner, since 22 May 2026).

Mahendrasingh Hanumansingh Chauhan was first appointed on 22 May 2026 as Designated Partner at Ai Prime Pathology And Diagnostics Llp.

The current boards of Mahendrasingh Hanumansingh Chauhan's companies include Shreekant Sharad Chobe (Ai Prime Pathology And Diagnostics Llp), Umakant Laxman Ballal (Ai Prime Pathology And Diagnostics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available